{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:20:34Z","timestamp":1694726434415},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00115-016-0249-z","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T09:44:21Z","timestamp":1480671861000},"page":"156-161","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Amyloid-Positronenemissionstomographie mit [18\u2009F]-Florbetaben in der Demenzdiagnostik"],"prefix":"10.1007","volume":"88","author":[{"given":"S.","family":"Sch\u00f6necker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Prix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Raiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ackl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Wlasich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Stenglein-Krapf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Brendel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Patt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Barthel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bartenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rominger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Danek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"key":"249_CR1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2011-0068","volume":"26","author":"H Barthel","year":"2011","unstructured":"Barthel H, Sabri O (2011) Florbetaben to trace amyloid-\u03b2 in the Alzheimer brain by means of PET. J Alzheimers Dis 26:117\u2013121","journal-title":"J Alzheimers Dis"},{"key":"249_CR2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TLS et\u00a0al (2012) Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. New Engl J Med 367:795\u2013804","journal-title":"New Engl J Med"},{"key":"249_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:CEMN.0000012721.08168.ee","volume":"24","author":"MM Bianchin","year":"2004","unstructured":"Bianchin MM, Capella HM, Chaves DL et al (2004) Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy \u2013 PLOSL): a\u00a0dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects. Cell Mol Neurobiol 24:1\u201324","journal-title":"Cell. Mol. Neurobiol."},{"key":"249_CR4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40336-014-0098-3","volume":"3","author":"AM Catafau","year":"2015","unstructured":"Catafau AM, Bullich S (2015) Amyloid PET imaging: applications beyond Alzheimer\u2019s disease. Clin Transl Imaging 3:39\u201355","journal-title":"Clin Transl Imaging"},{"key":"249_CR5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00005072-199904000-00008","volume":"58","author":"D Davis","year":"1999","unstructured":"Davis DG, Schmitt FA, Wekstein DR et\u00a0al (1999) Alzheimer neuropathologic alterations in aged cognitively normal subjects. J\u00a0Neuropathol Exp Neurol 58:376\u2013388","journal-title":"J Neuropathol Exp Neurol"},{"key":"249_CR6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS, Thomas RG, Farlow M et al (2014) Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med 370:311\u2013321","journal-title":"New Engl J Med"},{"key":"249_CR7","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B, Feldman HH, Jacova C et\u00a0al (2010) Revising the definition of Alzheimer\u2019s disease: a\u00a0new lexicon. Lancet Neurol 9:1118\u20131127","journal-title":"Lancet Neurol"},{"key":"249_CR8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006\u20131014","journal-title":"Neurology"},{"key":"249_CR9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000441139","volume":"41","author":"M Grundman","year":"2016","unstructured":"Grundman M, Johnson KA, Lu M et\u00a0al (2016) Effect of amyloid imaging on the diagnosis and management of patients with cognitive decline: impact of appropriate use criteria. Dement Geriatr Cogn Disord 41:80\u201392","journal-title":"Dement Geriatr Cogn Disord"},{"key":"249_CR10","first-page":"548157","volume":"2012","author":"S Guo","year":"2012","unstructured":"Guo S, Getsios D, Hernandez L et\u00a0al (2012) Florbetaben PET in the early diagnosis of alzheimer\u2019s disease: a\u00a0discrete event simulation to explore its potential value and key data gaps. Int J Alzheimers Dis 2012:548157","journal-title":"Int J Alzheimers Dis"},{"key":"249_CR11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr.","year":"2013","unstructured":"Jack CR Jr., Knopman DS, Jagust WJ et\u00a0al (2013) Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207\u2013216","journal-title":"Lancet Neurol"},{"key":"249_CR12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2967\/jnumed.113.120618","volume":"54","author":"KA Johnson","year":"2013","unstructured":"Johnson KA, Minoshima S, Bohnen NI et\u00a0al (2013) Appropriate use criteria for amyloid PET: a\u00a0report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer\u2019s Association. J\u00a0Nucl Med 54:476\u2013490","journal-title":"J Nucl Med"},{"key":"249_CR13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A et al (2004) Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh compound-B. Ann Neurol 55:306\u2013319","journal-title":"Ann. Neurol."},{"key":"249_CR14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM Mckhann","year":"2011","unstructured":"Mckhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 7:263\u2013269","journal-title":"Alzheimer\u2019s Dementia"},{"key":"249_CR15","doi-asserted-by":"publisher","DOI":"10.1159\/000058331","author":"MF Mendez","year":"2002","unstructured":"Mendez MF, Ghajarania M, Perryman KM (2002) Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 14:33\u201340. doi: 10.1159\/000058331","journal-title":"Dement Geriatr Cogn Disord"},{"key":"249_CR16","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA et al (1995) A\u00a0diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238\u20131248","journal-title":"J Nucl Med"},{"key":"249_CR17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","volume":"39","author":"JC Morris","year":"1989","unstructured":"Morris JC, Heyman A, Mohs RC et\u00a0al (1989) The Consortium to Establish a\u00a0Registry for Alzheimer\u2019s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer\u2019s disease. Neurology 39:1159\u20131165","journal-title":"Neurology"},{"key":"249_CR18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jnnp-2014-308094","volume":"86","author":"KT Ong","year":"2015","unstructured":"Ong KT, Villemagne VL, Bahar-Fuchs A et al (2015) Abeta imaging with 18\u202fF-florbetaben in prodromal Alzheimer\u2019s disease: a\u00a0prospective outcome study. J Neurol Neurosurg Psychiatry 86:431\u2013436","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"249_CR19","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.neuropsychologia.2011.04.012","volume":"49","author":"KE Pike","year":"2011","unstructured":"Pike KE, Ellis KA, Villemagne VL et al (2011) Cognition and beta-amyloid in preclinical Alzheimer\u2019s disease: data from the AIBL study. Neuropsychologia 49:2384\u20132390","journal-title":"Neuropsychologia"},{"key":"249_CR20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1192\/bjp.144.5.488","volume":"144","author":"PV Rabins","year":"1984","unstructured":"Rabins PV, Merchant A, Nestadt G (1984) Criteria for diagnosing reversible dementia caused by depression: validation by 2\u2011year follow-up. Br J Psychiatry 144:488\u2013492","journal-title":"Br J Psychiatry"},{"key":"249_CR21","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D et\u00a0al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456\u20132477","journal-title":"Brain"},{"key":"249_CR22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00002093-199601040-00002","volume":"10","author":"D Rasmusson","year":"1996","unstructured":"Rasmusson DX, Brandt J, Steele C et al (1996) Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzheimer Dis Assoc Disord 10:180\u2013188","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"249_CR23","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","volume":"68","author":"C Rowe","year":"2007","unstructured":"Rowe CC, Ng S, Ackermann U et al (2007) Imaging \u03b2\u2011amyloid burden in aging and dementia. Neurology 68:1718\u20131725","journal-title":"Neurology"},{"key":"249_CR24","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1056\/NEJM198906013202203","volume":"320","author":"B Rumble","year":"1989","unstructured":"Rumble B, Retallack R, Hilbich C et\u00a0al (1989) Amyloid A4 protein and its precursor in Down\u2019s syndrome and Alzheimer\u2019s disease. N Engl J Med 320:1446\u20131452","journal-title":"N. Engl. J. Med."},{"key":"249_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.02.004","author":"O Sabri","year":"2015","unstructured":"Sabri O, Sabbagh MN, Seibyl J et\u00a0al (2015) Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer\u2019s disease: phase 3 study. Alzheimers Dement 11:964\u2013974. doi: 10.1016\/j.jalz.2015.02.004","journal-title":"Alzheimers Dement"},{"key":"249_CR26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","volume":"370","author":"S Salloway","year":"2014","unstructured":"Salloway S, Sperling R, Fox NC et al (2014) Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease. N Engl J Med 370:322\u2013333","journal-title":"New Engl J Med"},{"key":"249_CR27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000339367","volume":"33","author":"C Schipke","year":"2012","unstructured":"Schipke CG, Peters O, Heuser I et al (2012) Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 33:416\u2013422","journal-title":"Dement Geriatr Cogn Disord"},{"key":"249_CR28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","volume":"68","author":"R Vandenberghe","year":"2010","unstructured":"Vandenberghe R, Van Laere K, Ivanoiu A et al (2010) 18\u202fF-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a\u00a0phase 2 trial. Ann Neurol 68:319\u2013329","journal-title":"Ann. Neurol."},{"key":"249_CR29","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archneurol.2009.285","volume":"66","author":"VL Villemagne","year":"2009","unstructured":"Villemagne VL, Ataka S, Mizuno T et al (2009) High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. Arch Neurol 66:1537\u20131544","journal-title":"Arch Neurol"},{"key":"249_CR30","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","volume":"51","author":"DF Wong","year":"2010","unstructured":"Wong DF, Rosenberg PB, Zhou Y et al (2010) In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18\u202fF-AV-45 (florbetapir F 18). J Nucl Med 51:913\u2013920","journal-title":"J. Nucl. Med."},{"key":"249_CR31","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World-Medical-Association","year":"2013","unstructured":"World Medical Association (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191\u20132194","journal-title":"JAMA"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-016-0249-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-016-0249-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-016-0249-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T05:56:16Z","timestamp":1568613376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-016-0249-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["249"],"URL":"https:\/\/doi.org\/10.1007\/s00115-016-0249-z","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,2]]}}}